Cite Filings / TELA / 0000950170-25-079686
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

TELA Bio, Inc. · Filed 2025-05-30 · Acc 0000950170-25-079686

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-05-30 8-K Executive or director change · Shareholder vote results
  • 2025-05-30 4 Director acquired 7,950 shares (grant or award)
  • 2025-05-30 4 Director acquired 7,950 shares (grant or award)
  • 2025-05-30 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-05-30 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-05-08 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Stonepine Capital Management, LLC 0.0%
  2. 2026-11-13 SCHEDULE 13G/A · North Run Capital, LP 7.8%
  3. 2026-11-13 SCHEDULE 13G/A · Nantahala Capital Management, LLC 14.50%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…